
![]() |
|||||||||||||
WJPR Citation
|
| All | Since 2020 | |
| Citation | 8502 | 4519 |
| h-index | 30 | 23 |
| i10-index | 227 | 96 |
A REVIEW ON PHARMACOLOGICAL MANAGEMENT OF ADHD IN CHILDREN AND ADOLESCENTS
Febina Razak* and Sudhamshu K. Tantry
. Abstract Attention deficit hyperactivity disorder (ADHD) is a neurocognitive behavioural developmental disorder most common in childhood and adolescence, often persisting into adulthood. Compared to a decade ago, extensive research has been conducted to understand the underlying factors of ADHD, which has led to more treatment options for the disorder. New formulations of stimulant medications have helped tailor treatment to the effective duration that patients require and have helped minimize the risks of misuse, abuse and diversion. In recent years, several new non-stimulant options have also emerged. Stimulants, including methylphenidate and amphetamine, are the main treatment for ADHD. This review summarizes currently available pharmacological treatment options for ADHD in children and adolescents. Keywords: Attention-deficit hyperactivity disorder, childhood, adolescents, treatment, stimulants, non-stimulants. [Full Text Article] [Download Certificate] |
